---
title: 'Funding Daily Summary: What Happened on November 18, 2026'
headline: Isomorphic Labs raises $5 billion in record biotech venture round
description: The AI drug-design company plans to move its preclinical pipeline toward
  clinical testing. Seawolf Therapeutics also launched with $100 million and a Sanofi
  deal.
url: https://thebench.bio/news/funding/2026-11-18
topic: funding
date: '2026-11-18'
covers:
- '2026-11-18'
date_published: '2026-11-18T12:02:28Z'
date_modified: '2026-11-18T12:02:28Z'
tags:
- Funding
- Software
sources: 6
publisher: TheBench.Bio
---

# Funding Daily Summary: What Happened on November 18, 2026

**Isomorphic Labs raises $5 billion in record biotech venture round**

The AI drug-design company plans to move its preclinical pipeline toward clinical testing. Seawolf Therapeutics also launched with $100 million and a Sanofi deal.

## Today in brief

Isomorphic Labs secured a $5 billion Series C, the largest biotech venture round on record, according to BioCentury’s database. [1] [2] It plans to use the funding to expand its AI drug-design platform and move its pipeline toward clinical testing. [1] [2]

Seawolf Therapeutics launched with $100 million in Series A funding and a Sanofi deal worth up to $1.2 billion in potential milestone payments. [3]

## Isomorphic raises $5 billion as its programs remain preclinical

Greenoaks Capital and Sequoia Capital co-led Isomorphic Labs’ $5 billion Series C, with Andreessen Horowitz and existing investors also participating. [1] [2] [4] Alphabet continued to invest. [2] [4]

The round breaks the previous record of $3 billion, raised by Altos Labs. [1] [3]

Isomorphic said it will use the proceeds to expand its AI drug-design engine, biological models, and infrastructure for translational and clinical development. [2] [4] The company reports positive preclinical results in oncology and immunology, but its internal programs have not entered clinical testing. [3] [4]

The Series C came six months after Isomorphic raised $2.1 billion in a Series B. [1] [4] Across three rounds since March 2025, the company has disclosed $7.7 billion in fundraising. [1] [4]

Before the financing, Bloomberg reported that Isomorphic was seeking a valuation of about $50 billion. [1] [5]

## Seawolf launches with $100 million and a Sanofi deal

Seawolf Therapeutics emerged from stealth with a $100 million Series A and a multi-target agreement with Sanofi. [3] The deal could provide up to $1.2 billion in milestone payments. [3]

## Also worth knowing

- Orakl Oncology raised $34 million in a Series A to expand into lung and gastric cancer. It says its model predicts trial outcomes with 90% accuracy in a preprint that has not been peer reviewed. [3]
- Flagship Pioneering committed £100 million to establish its first company-creation lab outside the United States, in London. [6]
- INFevo raised more than CNY 100 million in a Pre-A round to expand its virtual-cell models and automated laboratory platform. [6]

## The day in numbers

- **$5 billion**: Isomorphic Labs’ Series C, the largest biotech venture round on record according to BioCentury’s database. [1]
- **$7.7 billion**: Isomorphic Labs’ disclosed fundraising across three rounds since March 2025. [4]
- **$100 million**: Seawolf Therapeutics’ Series A at its emergence from stealth. [3]
- **£100 million**: Flagship Pioneering’s initial commitment to its London company-creation lab. [6]

## Also published

- [Isomorphic Labs raises $5bn in massive third round](<https://pharmaphorum.com/news/isomorphic-labs-raises-5bn-massive-third-round>), pharmaphorum
- [AI drugmaker Isomorphic restocks with $5B fundraise](<https://www.biopharmadive.com/news/isomorphic-labs-ai-drug-discovery-financing/874863/>), BioPharma Dive

## Sources

1. [Isomorphic raises record $5B round before naming a development candidate](<https://www.biocentury.com/article/661647/isomorphic-raises-record-5b-round-before-naming-a-development-candidate?utm_source=bc_rss&utm_medium=rss>), BioCentury, 2026-11-18
2. [Isomorphic Labs raises $5bn to advance drug pipeline](<https://www.pharmaceutical-technology.com/news/isomorphic-labs-5bn-advance-drug-pipeline/>), Pharmaceutical Technology, 2026-11-18
3. [Weekly Tech+Bio #91: The Largest Venture Round in TechBio History](<https://www.techlifesci.com/p/weekly-techbio-91-the-largest-venture>), Weekly Tech+Bio, 2026-11-17
4. [Isomorphic Labs raises $5B six months after $2.1B round](<https://european-biotechnology.com/latest-news/isomorphic-labs-raises-5b-six-months-after-2-1b-round/>), European Biotechnology, 2026-11-17
5. [Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials](<https://techcrunch.com/2026/11/17/isomorphic-labs-raises-5b-as-it-looks-to-take-drug-candidates-to-clinical-trials/>), TechCrunch Biotech and Health, 2026-11-17
6. [Latest News on TechBio Revolution](<https://marinatalamanou.substack.com/p/latest-news-on-techbio-revolution-9d3>), MetaphysicalCells, 2026-11-17

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://www.biocentury.com/article/661647/isomorphic-raises-record-5b-round-before-naming-a-development-candidate?utm_source=bc_rss&utm_medium=rss>
[2]: <https://www.pharmaceutical-technology.com/news/isomorphic-labs-5bn-advance-drug-pipeline/>
[3]: <https://www.techlifesci.com/p/weekly-techbio-91-the-largest-venture>
[4]: <https://european-biotechnology.com/latest-news/isomorphic-labs-raises-5b-six-months-after-2-1b-round/>
[5]: <https://techcrunch.com/2026/11/17/isomorphic-labs-raises-5b-as-it-looks-to-take-drug-candidates-to-clinical-trials/>
[6]: <https://marinatalamanou.substack.com/p/latest-news-on-techbio-revolution-9d3>
